From Breastcancer.org <[email protected]>
Subject When COVID-19 and Breast Cancer Collide
Date May 27, 2020 12:01 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Living With Cancer During the Pandemic
Shirley Mertz, a leading advocate for metastatic breast cancer, knows
firsthand how it feels to face every day with a cancer diagnosis while
avoiding the dangers of COVID-19, which threatens the health and
safety of immunocompromised patients. Hear her insights about how to
cope with treatment delays and the challenges of the COVID-19 pandemic.
Listen: [link removed]

Uncovering the Biggest COVID-19 Treatment Delays
We know COVID-19 has touched everyone's lives in some way, but how is
COVID-19 specifically impacting breast cancer patients' treatment,
care, and prognoses? We think about this question every single day.
Breastcancer.org is dedicated to finding the answers and sharing them
with the world. You are our partner in this effort, and truly, we can't
do it without you.
Answer Survey: [link removed]

Connect and Learn With the Breastcancer.org Community
Support, friendship, and shared experiences bring us together, even
when we're apart. You're not alone in coping with breast cancer or the
COVID-19 pandemic. Be part of the conversation in our community.
Join Us: [link removed]

News for Metastatic Triple-Negative Breast Cancer With High Levels of PD-L1
New research shows that the immunotherapy drug Keytruda given along with
chemotherapy offered better progression-free survival than
chemotherapy alone as the first treatment for metastatic
triple-negative breast cancer or triple-negative breast cancer that
has come back in the breast area but can't be surgically removed.
Learn More: [link removed]

If you are struggling right now, find more information in our ongoing
coverage of COVID-19: Coronavirus: What People With Breast Cancer
Need to Know at [link removed]

This special content is made possible in part through generous support
from AstraZeneca, Eisai, Lilly Oncology, Seattle Genetics, an
independent educational grant from Merck & Co., Inc., and
individuals like you.

Breastcancer.org
120 East Lancaster Avenue, Suite 201, Ardmore, PA 19003
Breastcancer.org is a nonprofit 501(c)(3) organization.

Donate: [link removed]
Visit Us Online: [link removed]



To unsubscribe from all future email, paste the following URL into your browser:
[link removed]
Screenshot of the email generated on import

Message Analysis